• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL UNKNOWN TISSUE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL UNKNOWN TISSUE HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number UNK TISSUE HEART VALVE
Device Problems Off-Label Use (1494); Patient-Device Incompatibility (2682)
Patient Problems Anemia (1706); Aneurysm (1708); Erosion (1750); Dyspnea (1816); Hemolysis (1886); Unspecified Infection (1930); Sepsis (2067); Pseudoaneurysm (2605); Heart Failure/Congestive Heart Failure (4446)
Event Date 04/19/2023
Event Type  Injury  
Event Description
The article, "repeat aortic valve replacement (avr) for pseudoaneurysm of mitral aortic intervalvular fibrosa (p maivf) repair due to hemolytic anemia 6 years after avr: a case report", was reviewed.The article presented a case study of a 55-year-old male patient with congenital aortic bicuspid valve and severe aortic stenosis.It was reported that on an unknown date, a 25mm unknown sjm/abbott aortic valve was implanted for off label use in a bicuspid aortic valve.Six years post-procedure on an unknown date, the patient presented with sepsis due to methicillin-sensitive staphylococcus aureus and infected abdominal aortic aneurysm (iaaa).The patient was discharged on the 25th hospitalization day under oral antibiotic medication following intravenous antibiotic therapy.It was then reported four months later the patient presented for shortness of breath, jaundice due to hemolytic anemia, and transesophageal echocardiography (tee) revealed pseudoaneurysm behind aortic valve.Transthoracic echocardiography (tte) showed mild aortic regurgitation from the dorsal circumference of the prosthetic valve.A decision was made to perform repeat aortic valve replacement with pseudoaneurysm of the mitral-aortic intervalvular fibrosa (p-maivf) repair.After removal of the 25mm valve, a 20mm x 15mm defect was confirmed for the first time in the left ventricular outflow tract just below the non-coronary cusp of the native aortic valve.There were no macroscopic findings of active infection around the defect and bacterial culture results during surgery were negative.The defect was closed with a 28mm x 23mm bovine pericardial patch and a 23mm carpentier edwards inspiris valve was implanted.The patient was discharged 12 days after surgery.The article concluded the present case was considered to be a very rare case in which surgery was performed because the blood flow entering and leaving the p-maivf contacted the prosthetic valve ring, resulting in hemolysis, severe anemia, and heart failure.[the primary and corresponding author was masanobu yamauchi, shimane prefectural central hospital, 4 chome 1-1, himebara, izumo city, shimane 693-8555, japan, with corresponding email: yamauchi@spch.Izumo.Shimane.Jp].
 
Manufacturer Narrative
Literature article: repeat aortic valve replacement (avr) for pseudoaneurysm of mitral aortic intervalvular fibrosa (p maivf) repair due to hemolytic anemia 6 years after avr: a case report d4 - the udi number is not known as the part and lot numbers were not provided investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
As reported in a research article, repeat aortic valve replacement (avr) for pseudoaneurysm of mitral aortic intervalvular fibrosa (p maivf) repair due to hemolytic anemia 6 years after avr.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN TISSUE HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG#3007113487
177 county road b east
st. paul MN 55117 1789
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18668588
MDR Text Key334906608
Report Number2135147-2024-00573
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/08/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK TISSUE HEART VALVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age55 YR
Patient SexMale
-
-